Herbs for benign prostatic hyperplasia

被引:0
作者
Dvorkin, L [1 ]
Song, KY [1 ]
机构
[1] Massachusetts Coll Pharm & Hlth Sci, Ctr Integrat Therapies Pharmaceut Care, Boston, MA 02115 USA
关键词
alternative medicine; benign prostatic hyperplasia; herbal therapy;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review and evaluate the literature relative to the use of herbal therapies in the treatment of benign prostatic hyperplasia. DATA SOURCES: Literature was identified by MEDLINE, Embase, International Pharmaceutical Abstracts, and the International Bibliographic Information on Dietary Supplements searches and through cross-referencing of selected articles. STUDY SELECTION/DATA EXTRACTION: All articles identified from the data sources were evaluated and all information deemed relevant was included in this review. DATA SYNTHESIS: A large percentage of men >50 years old begin to experience signs and symptoms of benign prostatic hyperplasia (BPH). Herbs hold promise in the treatment of BPH. Serenoa repens, Pygeum africanum, Urtica dioica radix, and Cucurbita peponis semen are some of the botanical therapies used in the treatment of BPH. CONCLUSIONS: There are many European studies examining efficacy, dose, and adverse effects of these plants in the treatment of BPH. However, numerous questions remain. These include issues concerning long-term beneficial and adverse effects of herbal therapy, prevention of complications, standardization of extracts, and concomitant use with "mainstream" medications. Based on the information available today, these botanical therapies can be used for treatment of a number of objective and subjective symptoms in patients with BPH, stages I and II.
引用
收藏
页码:1443 / 1452
页数:10
相关论文
共 50 条
[21]   Prostatic stents for the treatment of benign prostatic hyperplasia [J].
VanderBrink, Brian A. ;
Rastinehad, Ardeshir R. ;
Badlani, Gopal H. .
CURRENT OPINION IN UROLOGY, 2007, 17 (01) :1-6
[22]   Association of the Benign Prostatic Hyperplasia and erectile dysfunction, the current treatment modalities in Benign Prostatic Hyperplasia [J].
Sen, Volkan ;
Demir, Omer ;
Esen, Ahmet Adil .
UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (04) :62-64
[23]   Metabolic Syndrome and Benign Prostatic Hyperplasia/What Component of Metabolic Syndrome Is Related to Benign Prostatic Hyperplasia? [J].
Tarim, Bahar Arican ;
Camur, Emre ;
Kavukoglu, Ovunc ;
Kosemen, Mete ;
Ozgur, Yasemin ;
Narter, Kamil Fehmi .
JOURNAL OF UROLOGICAL SURGERY, 2023, 10 (03) :194-198
[24]   Biomarkers for the Diagnosis of Prostatic Inflammation in Benign Prostatic Hyperplasia [J].
Robert, Gregoire ;
Smit, Frank ;
Hessels, Daphne ;
Jannink, Sander ;
Karthaus, Herbert F. M. ;
Aalders, Tilly ;
Jansen, Kees ;
de la Taille, Alexandre ;
Mulders, Peter F. ;
Schalken, Jack A. .
PROSTATE, 2011, 71 (15) :1701-1709
[25]   Prostatic artery embolization for benign prostatic hyperplasia: a review [J].
Young, Shamar ;
Golzarian, Jafar .
CURRENT OPINION IN UROLOGY, 2018, 28 (03) :284-287
[26]   Autophagy in benign prostatic hyperplasia: insights and therapeutic potential [J].
Zhou, Xian-Zhao ;
Huang, Pei ;
Wu, Yao-Kan ;
Yu, Jin-Ben ;
Sun, Jie .
BMC UROLOGY, 2024, 24 (01)
[27]   Management of benign prostatic hyperplasia with silodosin [J].
Yamanishi, Tomonori ;
Mizuno, Tomoya ;
Kamai, Takao ;
Yoshida, Ken-Ichiro ;
Sakakibara, Ryuji ;
Uchiyama, Tomoyuki .
RESEARCH AND REPORTS IN UROLOGY, 2009, 1 :1-7
[28]   Laser treatment of benign prostatic hyperplasia [J].
Kuntz, Rainer M. .
WORLD JOURNAL OF UROLOGY, 2007, 25 (03) :241-247
[29]   Models for studying benign prostatic hyperplasia [J].
Mahapokai, W ;
van Sluijs, FJ ;
Schalken, JA .
PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (01) :28-33
[30]   Silodosin in the treatment of benign prostatic hyperplasia [J].
Rossi, Maxime ;
Roumeguere, Thierry .
DRUG DESIGN DEVELOPMENT AND THERAPY, 2010, 4 :291-297